Jiangsu Aidea Pharmaceutical Future Growth

Jiangsu Aidea Pharmaceutical is forecast to grow revenue at 42.1% per annum.

n/a

Earnings growth rate

n/a

EPS growth rate

No updates

Earnings and Revenue Growth Forecasts

XSSC:688488 - Analysts future estimates and past financials data (CNY Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	1,080	N/A	N/A	109	2
12/31/2025	835	N/A	N/A	-186	2
12/31/2024	509	N/A	N/A	1	2
9/30/2024	409	-105	-124	-58	N/A
6/30/2024	354	-112	-184	-125	N/A
3/31/2024	392	-90	-255	-180	N/A
12/31/2023	411	-76	-237	-166	N/A
9/30/2023	412	-80	-203	-115	N/A
6/30/2023	409	-66	-246	-146	N/A
3/31/2023	322	-101	-233	-123	N/A
12/31/2022	244	-124	-233	-93	N/A
9/30/2022	180	-114	-204	-69	N/A
6/30/2022	172	-111	-158	-31	N/A
3/31/2022	213	-64	-169	-41	N/A
12/31/2021	256	-30	-107	-12	N/A
9/30/2021	309	17	-129	-40	N/A
6/30/2021	317	28	-118	-31	N/A
3/31/2021	322	48	-9	44	N/A
12/31/2020	289	40	14	56	N/A
9/30/2020	327	51	16	41	N/A
6/30/2020	311	42	70	86	N/A
3/31/2020	309	31	70	90	N/A
12/31/2019	345	34	23	56	N/A
12/31/2018	277	9	-123	-33	N/A
12/31/2017	136	-38	N/A	-67	N/A

Earnings vs Savings Rate: Insufficient data to determine if 688488's forecast earnings growth is above the savings rate (2.9%).

Earnings vs Market: Insufficient data to determine if 688488's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 688488's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 688488's revenue (42.1% per year) is forecast to grow faster than the CN market (14% per year).

High Growth Revenue: 688488's revenue (42.1% per year) is forecast to grow faster than 20% per year.

Future ROE: 688488's Return on Equity is forecast to be low in 3 years time (3.7%).